Literature DB >> 20488574

Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes.

Naoto Katakami1, Munehide Matsuhisa, Hideaki Kaneto, Taka-aki Matsuoka, Kenichi Imamura, Fukashi Ishibashi, Tsutomu Kanda, Koichi Kawai, Takeshi Osonoi, Atsunori Kashiwagi, Ryuzo Kawamori, Iichiro Shimomura, Yoshimitsu Yamasaki.   

Abstract

We examined the association between diabetic retinopathy and monocyte chemoattractant protein (MCP)-1 A-2518G polymorphism in 3802 Japanese type 2 diabetic subjects. The prevalence of diabetic retinopathy was higher as the number of G alleles increased, suggesting that the G allele of this polymorphism is a susceptibility allele for diabetic retinopathy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20488574     DOI： 10.1016/j.diabres.2010.04.006

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  11 in total

Review 1.  Targeting inflammation in diabetes: Newer therapeutic options.

Authors:  Neeraj Kumar Agrawal; Saket Kant
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

3.  Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.

Authors:  Li Dong; Xiao Ying Lv; Bin Jie Wang; Ye Qing Wang; Hua Mu; Zhuo Lei Feng; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-09       Impact factor: 3.117

4.  CNS inflammation and bone marrow neuropathy in type 1 diabetes.

Authors:  Ping Hu; Jeffrey S Thinschmidt; Yuanqing Yan; Sugata Hazra; Ashay Bhatwadekar; Sergio Caballero; Tatiana Salazar; Jaleel A Miyan; Wencheng Li; Andrei Derbenev; Andrea Zsombok; Maria Tikhonenko; James M Dominguez; Susan P McGorray; Daniel R Saban; Michael E Boulton; Julia V Busik; Mohan K Raizada; Tailoi Chan-Ling; Maria B Grant
Journal:  Am J Pathol       Date:  2013-11       Impact factor: 4.307

5.  Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes.

Authors:  Hyun Jeong Jeon; Hyung Jin Choi; Byong Hee Park; Yong Hee Lee; Taekeun Oh
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

6.  Diabetic retinopathy and inflammation: novel therapeutic targets.

Authors:  Sampathkumar Rangasamy; Paul G McGuire; Arup Das
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

Review 7.  Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics.

Authors:  Aniruddha Agarwal; Mohamed K Soliman; Yasir J Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Pharmgenomics Pers Med       Date:  2014-12-12

8.  Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.

Authors:  Sampathkumar Rangasamy; Paul G McGuire; Carolina Franco Nitta; Finny Monickaraj; Sreenivasa R Oruganti; Arup Das
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 9.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

Review 10.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.